A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer. The prognostic signature could be reliable to stratify LUAD patients according to risk, which helps the management of the systematic treatments. In this study, a systematic and reliable immune signature was performed...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Transl Med
Asıl Yazarlar: Guo, Dina, Wang, Mian, Shen, Zhihong, Zhu, Jiaona
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7060601/
https://ncbi.nlm.nih.gov/pubmed/32143735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02286-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller